{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:08:59Z","timestamp":1789711739510,"version":"4.0.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe pneumonia is a major infectious complication in patients with leukemia and may rapidly progress to respiratory failure or septic shock. Disease- and treatment-related immunosuppression increases susceptibility, yet population-specific early risk-stratification tools are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To develop and externally validate a machine learning model for predicting severe pneumonia in hospitalized patients with leukemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 2,978 leukemia patients at two Chinese hospitals were retrospectively analyzed. The derivation cohort was divided into training and internal test sets; SMOTE was applied only to the training set. LASSO and SVM\u2013RFE were used for predictive feature selection, eight machine learning algorithms were compared, and RCS was used for exploratory association analysis. The final model was presented as a nomogram.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven predictors were retained: age, history of myelosuppression, acute lymphoblastic leukemia (ALL) subtype, cardiac insufficiency, atrial fibrillation, red blood cell distribution width\u2013standard deviation (RDW-SD), and prothrombin time activity. Logistic regression showed the best generalizability, with an area under the curve (AUC) of 0.801 in external validation. Sensitivity analyses showed similar discrimination with multiple imputation and complete-case analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed and externally validated an interpretable model for severe pneumonia in hospitalized patients with leukemia. Because direct programmed-cell-death biomarkers were not measured and SMOTE substantially altered training prevalence, mechanistic interpretation and absolute-risk calibration require caution. Prospective recalibration and clinical-impact evaluation are needed before routine use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2026.1943797","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:38:11Z","timestamp":1789709891000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-based early prediction of severe pneumonia risk in hospitalized leukemia patients: a dual-center retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Jian","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory, The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University","place":["Huai\u2019an, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinliang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Central Theater Command General Hospital of Chinese People\u2019s Liberation Army","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University","place":["Huai\u2019an, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University","place":["Huai\u2019an, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaogui","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University","place":["Huai\u2019an, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University","place":["Huai\u2019an, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University","place":["Huai\u2019an, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.3390\/ijms21051825","article-title":"Immune response dysfunction in chronic lymphocytic leukemia: dissecting molecular mechanisms and microenvironmental conditions","volume":"21","author":"Arruga","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(19)30037-6","article-title":"Reporting of artificial intelligence prediction models","volume":"393","author":"Collins","year":"2019","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s15010-025-02651-4","article-title":"Infections during AML induction chemotherapy in a contemporary cohort without fluoroquinolone prophylaxis","volume":"54","author":"Ehrlich","year":"2026","journal-title":"Infection"},{"key":"B8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00134-019-05872-y","article-title":"Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy","volume":"46","author":"Fleuren","year":"2020","journal-title":"Intensive Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.jtha.2024.03.020","article-title":"Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia","volume":"22","author":"Hisada","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"B12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.14578","article-title":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and Histiocytic\/Dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajem.2012.06.004","article-title":"Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia","volume":"31","author":"Lee","year":"2013","journal-title":"Am. J. Emerg. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"B18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/dna.2021.1072","article-title":"The emerging role of ferroptosis in sepsis","volume":"41","author":"Liu","year":"2022","journal-title":"DNA Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"154069","DOI":"10.1016\/j.jcrc.2022.154069","article-title":"Red blood cell distribution width as prognostic factor in sepsis: a new use for a classical parameter","volume":"71","author":"Moreno-Torres","year":"2022","journal-title":"J. Crit. Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver - guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/jcm14020389","article-title":"Diagnostic approach to pneumonia in immunocompromised hosts","volume":"14","author":"Ullah","year":"2025","journal-title":"J. Clin. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","article-title":"Advances in the understanding and treatment of sepsis-induced immunosuppression","volume":"14","author":"Venet","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"962139","DOI":"10.3389\/fcimb.2022.962139","article-title":"Molecular mechanisms and functions of pyroptosis in sepsis and sepsis-associated organ dysfunction","volume":"12","author":"Wen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1943797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:38:13Z","timestamp":1789709893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1943797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":26,"alternative-id":["10.3389\/fcell.2026.1943797"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1943797","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1943797"}}